Cardinal Health sets November 5 results date for Cardinal Health stock

Published on 10/21/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health will report first-quarter results on November 5, 2026. Cardinal Health stock costs EUR 230.20 on October 21, 2026.

Results and customer scale

Cardinal Health announced fiscal 2027 first-quarter results for November 5, 2026.
Fiscal 2026 revenue reached USD 254.2 billion, up 14 percent from fiscal 2025.
Cardinal Health stock trades at EUR 230.20 at 11:11 a.m. CEST at Lang & Schwarz on October 21, 2026.
CVS represented 28 percent of fiscal 2026 revenue under the extended distribution relationship.

Schwarzweiß-Reportage an der Verladerampe eines Pharma-Distributionszentrums — Cardinal Health Inc. zeigt eine SW-Reportage der Verladerampe im Pharma-Lager ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) stock costs EUR 230.20 at Lang & Schwarz on October 21, 2026 at 11:11 a.m. CEST. The company will report first-quarter fiscal 2027 results on November 5, 2026, before trading opens in New York, according to Cardinal Health.

Revenue reached USD 254.2 billion

Fiscal 2026 revenue reached USD 254.248 billion, compared with USD 222.578 billion in fiscal 2025, while net income attributable to Cardinal Health rose to USD 1.714 billion from USD 1.561 billion. The fiscal 2026 figures cover the year ended June 30, 2026, and were reported in the company's annual results.

LineVest reported that operating profit increased to USD 2.613 billion in fiscal 2026 from USD 2.275 billion in fiscal 2025. Operating cash flow also rose to USD 5.174 billion from USD 2.397 billion, although payment timing contributed materially to the increase.

What does the CVS extension add?

On October 1, 2026, Cardinal Health entered a binding letter of intent to extend its pharmaceutical distribution relationship with CVS Health through June 30, 2032. CVS represented 28 percent of Cardinal Health's USD 254.2 billion fiscal 2026 revenue, according to Distribution Strategy Group. The contract supports customer continuity, while concentration remains a material factor in the business profile.

Three dated developments

On November 3, 2025, Cardinal Health completed the Solaris Health acquisition for approximately USD 1.9 billion. On August 11, 2026, it reported fiscal 2026 revenue of USD 254.2 billion and diluted earnings per share of USD 7.23. On October 1, 2026, it announced the CVS distribution extension through June 30, 2032.

Upcoming reporting dates

Cardinal Health is scheduled to release first-quarter fiscal 2027 results on November 5, 2026, before the New York market opens. The company's annual general meeting is scheduled for November 12, 2026, according to Simply Wall St.

Stock valuation and next test

Cardinal Health had a USD 59.6 billion market capitalization as of October 20, 2026, while its primary listing is on the New York Stock Exchange. The next quarterly report will show whether fiscal 2027 earnings growth is keeping pace with the company's expanded pharmaceutical and specialty operations.

Cardinal Health was trading at EUR 230.20 at Lang & Schwarz on October 21, 2026 at 11:11 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.